Ligence
Private Company
Funding information not available
Overview
Ligence is a Zurich-based digital health company founded in 2019, focusing on AI-driven automation of echocardiography analysis. Its core platform, Ligence Heart™, is a certified, vendor-neutral software suite designed to integrate into clinical workflows, cut reporting time, and standardize measurements according to established cardiology guidelines. The company has achieved key regulatory milestones in the US and EU and is backed by published research in leading journals, positioning it to address significant inefficiencies in cardiac ultrasound diagnostics.
Technology Platform
Web-based AI software platform for automated segmentation and quantification of cardiac structures from 2D transthoracic echocardiograms (TTE). It is vendor-neutral, integrates with hospital IT, and generates guideline-compliant reports.
Opportunities
Risk Factors
Competitive Landscape
Ligence competes in the growing market of AI-assisted echocardiography analysis. Competitors include specialized AI startups (e.g., Ultromics, Us2.ai, EchoIQ), as well as in-house solutions being developed by major ultrasound device manufacturers (e.g., GE HealthCare, Philips, Siemens Healthineers). Ligence's key differentiators are its vendor neutrality and emphasis on seamless workflow integration.